Bridge City Capital LLC Acquires 12,695 Shares of U.S. Physical Therapy, Inc. $USPH

Key Points

• Bridge City Capital increased its U.S. Physical Therapy stake by 18.7% in the third quarter, purchasing 12,695 shares and bringing its holdings to 80,585 shares worth approximately $6.9 million.
• U.S. Physical Therapy reported quarterly revenue of $214.1 million, up 8.5% year over year and above estimates, but earnings per share of $0.75 fell short of the $0.81 analyst consensus.
• Analysts maintain a generally positive outlook, with a “Moderate Buy” consensus and an average price target of $98.25 versus the reported share price of $85.63; the company also pays a quarterly dividend of $0.46.

Bridge City Capital LLC grew its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 18.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,585 shares of the company's stock after buying an additional 12,695 shares during the quarter. U.S. Physical Therapy makes up 1.4% of Bridge City Capital LLC's portfolio, making the stock its 27th largest position. Bridge City Capital LLC owned about 0.54% of U.S. Physical Therapy worth $6,909,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in USPH. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in U.S. Physical Therapy during the 2nd quarter worth about $30,000. Sterling Capital Management LLC lifted its stake in shares of U.S. Physical Therapy by 221.0% during the 3rd quarter. Sterling Capital Management LLC now owns 443 shares of the company's stock valued at $38,000 after buying an additional 305 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new position in shares of U.S. Physical Therapy in the second quarter valued at $33,000. Parallel Advisors LLC increased its holdings in U.S. Physical Therapy by 75.2% during the 1st quarter. Parallel Advisors LLC now owns 785 shares of the company's stock worth $59,000 after acquiring an additional 337 shares during the period. Finally, Verdence Capital Advisors LLC bought a new stake in U.S. Physical Therapy during the third quarter valued at $232,000.

U.S. Physical Therapy Price Performance

USPH opened at $85.63 on Monday. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.48. The company has a market cap of $1.28 billion, a P/E ratio of 503.74, a P/E/G ratio of 2.18 and a beta of 1.12. U.S. Physical Therapy, Inc. has a 52-week low of $58.19 and a 52-week high of $90.94. The company has a 50 day moving average of $82.87 and a two-hundred day moving average of $76.92.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing analysts' consensus estimates of $0.81 by ($0.06). U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The company had revenue of $214.06 million for the quarter, compared to analyst estimates of $211.36 million. During the same quarter last year, the company posted $0.81 EPS. U.S. Physical Therapy's revenue was up 8.5% on a year-over-year basis. On average, analysts expect that U.S. Physical Therapy, Inc. will post 2.89 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 21st were issued a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Friday, August 21st. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 1,082.35%.

Analysts Set New Price Targets

Several research analysts recently commented on USPH shares. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. JPMorgan Chase & Co. upped their target price on U.S. Physical Therapy from $90.00 to $95.00 and gave the company an "overweight" rating in a research note on Friday, September 11th. Barrington Research lifted their price target on U.S. Physical Therapy from $90.00 to $98.00 and gave the company an "outperform" rating in a report on Monday, August 10th. Finally, Citigroup restated a "market outperform" rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 19th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $98.25.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc NYSE: USPH operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.